XML 104 R86.htm IDEA: XBRL DOCUMENT v3.24.0.1
Business Segment and Geographic Data Information (Information Concerning Consolidated Operations by Business Segment) (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues [1]   $ 20,431 $ 20,175 $ 19,440
Depreciation and amortization   753 754 766
Operating Profit [2]   2,344 2,681 2,561
Other (income) expense, net [2],[3]   69 (43) 28
Capital Spending   766 876 1,007
Assets   17,344 17,970 17,837
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain   0 (85) 0
Thinx, Inc.        
Business Combination, Acquisition Related Costs $ 21      
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain $ (85)      
United States        
Revenues   10,362 9,848 9,285
Personal Care        
Revenues [1]   10,691 10,622 10,267
Depreciation and amortization   387 375 355
Operating Profit [2]   1,890 1,787 1,856
Capital Spending   342 442 536
Assets   7,999 9,086 8,890
Consumer Tissue        
Revenues [1]   6,290 6,243 6,034
Depreciation and amortization   236 251 291
Operating Profit [2]   976 806 888
Capital Spending   285 280 303
Assets   4,935 5,048 5,083
K-C Professional and Other        
Revenues [1]   3,404 3,256 3,072
Depreciation and amortization   127 125 116
Operating Profit [2]   665 457 404
Capital Spending   123 142 157
Assets   2,507 2,675 2,650
Corporate and Other        
Revenues [1]   46 54 67
Depreciation and amortization   3 3 4
Operating Profit [2],[4]   (1,118) (412) (559)
Capital Spending   16 12 11
Assets   $ 1,903 $ 1,161 1,214
2018 Global Restructuring Program | Personal Care        
Restructuring Charges       104
2018 Global Restructuring Program | Consumer Tissue        
Restructuring Charges       118
2018 Global Restructuring Program | K-C Professional and Other        
Restructuring Charges       40
Corporate and Other | 2018 Global Restructuring Program        
Restructuring Charges       $ 265
[1] Net sales in the U.S. to third parties totaled $10,362, $9,848 and $9,285 in 2023, 2022 and 2021, respectively. No other individual country's net sales exceeds 10 percent of total net sales.
[2] Segment operating profit excludes Other (income) and expense, net and income and expenses not associated with the business segments.
[3] Other (income) and expense, net in 2023 includes the gain of $74 related to the sale of our Brazil tissue and K-C Professional business, and in 2022 includes the non-cash, non-recurring gain of $85 related to the acquisition of a controlling interest in Thinx.
[4] Corporate & Other in 2023 includes divestiture-related costs associated with the sale of our Brazil tissue and K-C Professional business of $30 and the charges related to the impairment of intangible assets of $658. In 2022, it includes transaction and integration costs of $21 related to the acquisition of a controlling interest in Thinx, and in 2021, it includes charges of $265 related to the 2018 Global Restructuring Program. Restructuring charges in 2021 related to the Personal Care, Consumer Tissue and K-C Professional business segments were $104, $118 and $40, respectively.